Retacnyl tretinoin cream 0.05 review năm 2024

Tretinoin. A review of its pharmacological properties and clinical efficacy in the topical treatment of photodamaged skin

S Noble et al. Drugs Aging. 1995 Jun.

Abstract

Tretinoin (all-trans-retinoic acid) is a retinol (vitamin A) derivative which has been evaluated as a topical treatment for the symptoms of photodamaged skin. In several well-controlled clinical trials, the proportion of patients showing improvement was significantly higher with 0.01 or 0.05% tretinoin cream than with placebo for criteria such as global assessment, fine and coarse wrinkling, pigmentation and roughness. Improvements in the overall severity of photodamage were also significantly greater with tretinoin than with placebo. The extent of clinical improvement with tretinoin has generally been moderate, but cytological and histological studies have shown that extensive changes in the epidermis and dermis occur during treatment. However, the permanency and clinical significance of these changes has yet to be fully evaluated. Topical tretinoin has also demonstrated potential for the treatment and eradication of premalignant skin growths such as actinic keratoses, and may be useful as combination therapy with fluorouracil in this indication. Dermatitis (the retinoid skin reaction) is the most common adverse event experienced by patients receiving topical tretinoin; this condition may persist for up to 3 months, but is usually mild or moderate in nature. Thus, topical tretinoin has been shown to be an effective form of treatment for the characteristic signs of photodamaged skin. Its ability to produce significant, albeit moderate, clinical improvements in symptoms such as fine wrinkling, roughness and pigmentation, together with its relatively mild or moderate adverse event profile, suggests that it is likely to be of considerable value in this indication. The treatment and eradication of potentially malignant growths such as actinic keratoses may also prove to be an important application for topical tretinoin.

PubMed Disclaimer

Similar articles

  • Interventions for photodamaged skin. Samuel M, Brooke RC, Hollis S, Griffiths CE. Samuel M, et al. Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001782. doi: 10.1002/14651858.CD001782.pub2. Cochrane Database Syst Rev. 2005. PMID: 15674885 Updated. Review.
  • Topical tretinoin for photoaged skin. Kligman AM, Grove GL, Hirose R, Leyden JJ. Kligman AM, et al. J Am Acad Dermatol. 1986 Oct;15(4 Pt 2):836-59. doi: 10.1016/s0190-9622(86)70242-9. J Am Acad Dermatol. 1986. PMID: 3771853 Clinical Trial.
  • Retinoids and photodamage. Gilchrest BA. Gilchrest BA. Br J Dermatol. 1992 Sep;127 Suppl 41:14-20. doi: 10.1111/j.1365-2133.1992.tb16982.x. Br J Dermatol. 1992. PMID: 1390181 Review.
  • Long-term clinical experience with a topical retinoid. Thorne EG. Thorne EG. Br J Dermatol. 1992 Sep;127 Suppl 41:31-6. doi: 10.1111/j.1365-2133.1992.tb16985.x. Br J Dermatol. 1992. PMID: 1390184
  • Topical tretinoin for treatment of photodamaged skin. A multicenter study. Weinstein GD, Nigra TP, Pochi PE, Savin RC, Allan A, Benik K, Jeffes E, Lufrano L, Thorne EG. Weinstein GD, et al. Arch Dermatol. 1991 May;127(5):659-65. Arch Dermatol. 1991. PMID: 2024983 Clinical Trial.

Cited by

  • Identifying circRNA-miRNA-mRNA Regulatory Networks in Chemotherapy-Induced Peripheral Neuropathy. Cao F, Wang X, Ye Q, Yan F, Lu W, Xie J, Bi B, Wang X. Cao F, et al. Curr Issues Mol Biol. 2023 Aug 16;45(8):6804-6822. doi: 10.3390/cimb45080430. Curr Issues Mol Biol. 2023. PMID: 37623249 Free PMC article.
  • Exploring the interactions of antihistamine with retinoic acid receptor beta (RARB) by molecular dynamics simulations and genome-wide meta-analysis. Kim MJ, Kulkarni V, Goode MA, Sivesind TE. Kim MJ, et al. J Mol Graph Model. 2023 Nov;124:108539. doi: 10.1016/j.jmgm.2023.108539. Epub 2023 Jun 9. J Mol Graph Model. 2023. PMID: 37331258
  • Benefits of the Dermocosmetic Mineral 89 Probiotic Fractions Adjunct to Topical Retinoids for Anti-Aging Benefits. Valpaços C, Leclerc-Mercier S, Lopes L, Svoboda D, Miranda D, Correia P, Junior J, Fernandes E, Francois-Newton V, Mandary MB, Gueniche A, Tan J, Kerob D. Valpaços C, et al. Clin Cosmet Investig Dermatol. 2023 Feb 10;16:375-385. doi: 10.2147/CCID.S396952. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 36798538 Free PMC article.
  • PLCγ1 inhibition combined with inhibition of apoptosis and necroptosis increases cartilage matrix synthesis in IL-1β-treated rat chondrocytes. Chen X, Chen R, Xu Y, Xia C. Chen X, et al. FEBS Open Bio. 2021 Feb;11(2):435-445. doi: 10.1002/2211-5463.13064. Epub 2020 Dec 31. FEBS Open Bio. 2021. PMID: 33326693 Free PMC article.

Endogenous and combination retinoids are active in myelomonocytic leukemias.

Di Martino O, Niu H, Hadwiger G, Kuusanmaki H, Ferris MA, Vu A, Beales J, Wagner C, Menéndez-Gutiérrez MP, Ricote M, Heckman C, Welch JS.

What is Retacnyl 0.05 cream used for?

In summary, Retacnyl 0.05 is indicated for the treatment of acne and certain conditions that make it difficult to form the stratum corneum of the skin.

Is 0.05 tretinoin cream effective?

“The strength of tretinoin prescribed for anti-aging will depend on multiple factors. However, in general, a low to moderate strength of tretinoin (0.025% to 0.05%) is often recommended for anti-aging purposes, because it tends to be effective while minimizing the risk of irritation,” she added.

Can I use tretinoin 0.05 everyday?

Tretinoin can cause skin irritation and peeling, especially when you first start using it. To combat this, start slowly—using tretinoin every third night, then every other night, then nightly as your skin tolerates (Leyden, 2017). Exactly how quickly you ramp up depends on how you're tolerating the medication.

What is tretinoin .05 cream used for?

Tretinoin is used to treat acne or other skin diseases as determined by your doctor. It works partly by keeping skin pores clear. One of the tretinoin creams is used to treat fine wrinkles, dark spots, or rough skin on the face caused by the damaging rays of the sun.